FORATOL 200 ROTACAP

Product Description

FORATOL 200 ROTACAP Dual Bronchodilator Therapy for Effective Asthma & COPD Relief

Boost your respiratory product portfolio with FORATOL 200 ROTACAP, a high-efficacy inhalation therapy combining Formoterol Fumarate (6 mcg) and Budesonide (200 mcg). Designed for long-term management of asthma and Chronic Obstructive Pulmonary Disease (COPD), this dry powder capsule offers dual-action benefits: bronchodilation and anti-inflammatory control.

Key Benefits:

• Long-acting bronchodilator (Formoterol) provides rapid and sustained airway relaxation

• Inhaled corticosteroid (Budesonide) reduces airway inflammation for improved breathing

• Convenient Rotacap format ensures precise dosage with minimal systemic side effects

• Proven combination therapy for moderate to severe asthma and COPD management

Ideal For:

• Pharmaceutical distributors seeking high-demand respiratory solutions

• Hospital procurement teams and bulk medicine suppliers

• Retail pharmacists and B2B buyers in need of GMP-certified inhalation therapy products